Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Drug Resistance

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 195 articles: HTML format

Single Articles

July 2024
1. BOUTIN CA, Durocher F, Beauchemin S, Ziegler D, et al
   Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review.
   Clin Infect Dis. 2024;79:151-160.
   PubMed     Abstract available
   
   
   
2. EUBANK TA, Dureja C, Garey KW, Hurdle JG, et al
   Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response.
   Clin Infect Dis. 2024;79:15-21.
   PubMed     Abstract available
   
   
   
3. GROSSMAN MK, Rankin DA, Maloney M, Stanton RA, et al
   Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears.
   Clin Infect Dis. 2024;79:6-14.
   PubMed     Abstract available
   
   
   
4. HEIL EL
   Put the Fluoroquinolone Down and No One Gets Hurt.
   Clin Infect Dis. 2024;79:1-2.
   PubMed    
   
   
   
5. GOTO M
   A Call for a Reinvention of Antibiogram.
   Clin Infect Dis. 2024;79:282.
   PubMed    
   
   
   June 2024
6. SENCHYNA F, Murugesan K, Rotunno W, Nadimpalli SS, et al
   Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-beta-lactamase-Producing Escherichia coli Causing Fatal Bloodstream Infection.
   Clin Infect Dis. 2024;78:1425-1428.
   PubMed     Abstract available
   
   
   
7. COOPER LN, Beauchamp AM, Ingle TA, Diaz MI, et al
   Socioeconomic Disparities and the Prevalence of Antimicrobial Resistance.
   Clin Infect Dis. 2024 Jun 7:ciae313. doi: 10.1093.
   PubMed     Abstract available
   
   
   May 2024
8. PINEDA-REYES R, Neil BH, Orndorff J, Williams-Bouyer N, et al
   Clinical presentation, antimicrobial resistance, and treatment outcomes of Aeromonas human infections: A 14-year retrospective study and comparative genomics of two isolates from fatal cases.
   Clin Infect Dis. 2024 May 17:ciae272. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. GETANDA P, Jagne I, Bognini JD, Camara B, et al
   Impact of Intrapartum Azithromycin on the Carriage and Antibiotic Resistance of Escherichia coli and Klebsiella pneumoniae in Mothers and their Newborns: a sub-study of a Randomized Double-Blind Trial Conducted in The Gambia and Burkina Faso.
   Clin Infect Dis. 2024 May 16:ciae280. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. WOLFE KH, Pierce VM, Humphries RM
    How New Regulation of Laboratory-Developed Antimicrobial Susceptibility Tests Will Affect Infectious Diseases Clinical Practice.
    Clin Infect Dis. 2024;78:1140-1147.
    PubMed     Abstract available
    
    
    
11. FALCONE M, Giordano C, Leonildi A, Galfo V, et al
    Clinical Features and Outcomes of Infections Caused by Metallo-beta-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area.
    Clin Infect Dis. 2024;78:1111-1119.
    PubMed     Abstract available
    
    
    
12. PETERSON B, Arzika AM, Amza A, Maliki R, et al
    Assessment of spillover of antimicrobial resistance to untreated children 7 to 12 years old after mass drug administration of azithromycin for child survival in Niger: a secondary analysis of the MORDOR cluster-randomized trial.
    Clin Infect Dis. 2024 May 13:ciae267. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
13. TAMMA PD, Immel S, Karaba SM, Soto CL, et al
    Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis with Sulbactam-Durlobactam.
    Clin Infect Dis. 2024 Apr 17:ciae210. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. MARINER-LLICER C, Saavedra Cervera B, Mambuque E, Gomes N, et al
    Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
    Clin Infect Dis. 2024;78:842-845.
    PubMed     Abstract available
    
    
    
15. SHIELDS RK, Cheng WY, Kponee-Shovein K, Indacochea D, et al
    Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in E. coli-Causing Uncomplicated Urinary Tract Infection.
    Clin Infect Dis. 2024 Apr 4:ciae171. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
16. 
    Correction to: Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) Supplement.
    Clin Infect Dis. 2024 Mar 29:ciae122. doi: 10.1093.
    PubMed    
    
    
    
17. HAZRA A, Celum C, Luetkemeyer AF, Molina JM, et al
    Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its well-Informed implementation.
    Clin Infect Dis. 2024 Mar 19:ciae152. doi: 10.1093.
    PubMed    
    
    
    
18. MOHANTY S, Ye G, Sheets C, Cossrow N, et al
    Association Between Social Vulnerability and Streptococcus pneumoniae Antimicrobial Resistance in US Adults.
    Clin Infect Dis. 2024 Mar 14:ciae138. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
19. BONOMO RA, Perez F, Hujer AM, Hujer KM, et al
    The Real Crisis in Antimicrobial Resistance: Failure to Anticipate and Respond.
    Clin Infect Dis. 2024 Jan 30:ciad758. doi: 10.1093.
    PubMed    
    
    
    
20. VAN WELZEN BJ, Van Lelyveld SFL, Ter Beest G, Gisolf JH, et al
    Virological failure after switch to long-acting cabotegravir and rilpivirine injectable therapy: an in-depth analysis.
    Clin Infect Dis. 2024 Jan 11:ciae016. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. URSENBACH A, Ruch Y, Hoellinger B, Fuchs A, et al
    Two cases of viral re-suppression after M184V + R263 K selection on DTG/3TC without treatment modification.
    Clin Infect Dis. 2024 Jan 9:ciae006. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
22. VAN DER VAART TW, Prins JM, Goorhuis A, Lemkes BA, et al
    The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low MRSA prevalence.
    Clin Infect Dis. 2023 Dec 29:ciad784. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. POPOVICH KJ, Aureden K, Ham DC, Harris AD, et al
    Reply to Diekema et al. "Are contact precautions "essential" for the prevention of healthcare-associated methicillin-resistant Staphylococcus aureus?".
    Clin Infect Dis. 2023 Dec 20:ciad777. doi: 10.1093.
    PubMed    
    
    
    
24. SUJAN MJ, Habib ZH, Rahman A, Rizvi SMS, et al
    Antimicrobial Resistance Surveillance Methods in Bangladesh: Present and Way Forward.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
25. ABOUSHADY AT, Sujan MJ, Pham K, Clark A, et al
    Key Recommendations for Antimicrobial Resistance Surveillance: Takeaways From the CAPTURA Project.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
26. HOLM M, MacWright WR, Poudyal N, Shaw AG, et al
    Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA).
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
27. MAHARJAN S, Gallagher P, Gautam M, Joh HS, et al
    Recording and Reporting of Antimicrobial Resistance (AMR) Priority Variables and Its Implication on Expanding Surveillance Sites in Nepal: A CAPTURA Experience.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
28. TADESSE BT, Keddy KH, Rickett NY, Zhusupbekova A, et al
    Vaccination to Reduce Antimicrobial Resistance Burden-Data Gaps and Future Research.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
29. GALLAGHER P, Shaw A, Bhandari A, Poudyal N, et al
    Considerations for Expanding Antimicrobial Resistance Surveillance Networks.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
30. LESLIE T, Parry C, Ondoa P, Walsh T, et al
    The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The CAPTURA Experience.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
31. JOH HS, Yeats C, Shaw A, Poudyal N, et al
    Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
32. JOH HS, Dolabella B, Early E, Stelling J, et al
    CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual).
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
33. POUDYAL N, Holm M, Joh HS, Gautam S, et al
    Effective Stakeholder Engagement for Collation, Analysis and Expansion of Antimicrobial Resistance (AMR) Data: A CAPTURA Experience.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
34. DOUD MB, Haste NM, Abeles SR
    Correspondence to Hasegawa et al. "Diagnostic Accuracy of Hospital Antibiograms in Predicting the Risk of Antimicrobial Resistance in Enterobacteriaceae Isolates: A Nationwide Multicenter Evaluation at the Veterans Health Administration".
    Clin Infect Dis. 2023 Dec 6:ciad748. doi: 10.1093.
    PubMed    
    
    
    
35. SANSOM SE, Gussin GM, Schoeny M, Singh RD, et al
    Rapid Environmental Contamination with Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients.
    Clin Infect Dis. 2023 Dec 6:ciad752. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. NHU NTQ, Young VB
    The Relationship Between the Microbiome and Antimicrobial Resistance.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    November 2023
37. MACDOUGALL C
    A Cloudy Crystal Ball: Critically Assessing and Rethinking the Antibiogram.
    Clin Infect Dis. 2023;77:1501-1503.
    PubMed    
    
    
    
38. MANHART LE, Leipertz G, Soge OO, Jordan SJ, et al
    Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions.
    Clin Infect Dis. 2023;77:1449-1459.
    PubMed     Abstract available
    
    
    
39. MISRA K, Huang JS, Udeagu CN, Forgione L, et al
    Pre-exposure prophylaxis (PrEP) use history in people with antiretroviral resistance at HIV diagnosis: Findings from New York City HIV surveillance and partner services, 2015-2022.
    Clin Infect Dis. 2023 Nov 17:ciad699. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. YASSIN A, Huralska M, Pogue JM, Dixit D, et al
    Executive Summary: State-of-the-Art Review: State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms.
    Clin Infect Dis. 2023;77:1223-1225.
    PubMed    
    
    
    
41. YASSIN A, Huralska M, Pogue JM, Dixit D, et al
    State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms.
    Clin Infect Dis. 2023;77:e46-e56.
    PubMed     Abstract available
    
    
    
42. ASLAM S
    Phage Therapy in Lung Transplantation: Current Status and Future Possibilities.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    October 2023
43. EVANS SR, Patel R, Hamasaki T, Howard-Anderson J, et al
    The Future Ain't What It Used to Be...Out With the Old...In With the Better: Antibacterial Resistance Leadership Group Innovations.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
44. CHAMBERS HF, Cross HR, Souli M, Evans SR, et al
    The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
45. CROSS HR, Greenwood-Quaintance KE, Souli M, Komarow L, et al
    Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
46. HANSON KE, Banerjee R, Doernberg SB, Evans SR, et al
    Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
47. SATLIN MJ, van Duin D, Tamma PD, Lodise TP, et al
    Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
48. JEZEK A, Del Rio C
    Antibacterial Resistance, Research, and Funding in 2024.
    Clin Infect Dis. 2023;77.
    PubMed    
    
    
    
49. HARRIS AD, Souli M, Pettigrew MM
    The Next Generation: Mentoring and Diversity in the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
50. DOERNBERG SB, Arias CA, Altman DR, Babiker A, et al
    Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
51. STRAUB TJ, Lombardo MJ, Bryant JA, Diao L, et al
    Impact of a purified microbiome therapeutic on abundance of antimicrobial resistance genes in patients with recurrent Clostridioides difficile infection.
    Clin Infect Dis. 2023 Oct 12:ciad636. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
52. DIEKEMA DJ, Nori P, Stevens MP, Smith MW, et al
    Are contact precautions "essential" for the prevention of healthcare-associated methicillin-resistant Staphylococcus aureus?
    Clin Infect Dis. 2023 Sep 21:ciad571. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. WANG M, Ge L, Chen L, Komarow L, et al
    Clinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant Acinetobacter baumannii Among Patients from Different Global Regions.
    Clin Infect Dis. 2023 Sep 20:ciad556. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. KASAIE P, Pennington J, Gupta A, Dowdy DW, et al
    The impact of preventive treatment for multidrug- and rifampin-resistant tuberculosis exceeds trial-based estimates.
    Clin Infect Dis. 2023 Sep 19:ciad557. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. COTTO O, Armand-Lefevre L, Matheron S, Ruppe E, et al
    Within-Host Dynamics and Duration of Colonization of Travel-Acquired Multidrug-Resistant Enterobacterales in Untreated Individuals.
    Clin Infect Dis. 2023;77:934-936.
    PubMed    
    
    
    
56. BOAST A, How JA, Lau C, Sett A, et al
    Pre-XDR congenital tuberculosis in an extremely premature baby.
    Clin Infect Dis. 2023 Sep 8:ciad540. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. 
    Correction to: Transmission of Carbapenem-Resistant Enterobacterales in an Overcrowded Emergency Department: Controlling the Spread to the Hospital.
    Clin Infect Dis. 2023 Sep 1:ciad509. doi: 10.1093.
    PubMed    
    
    
    August 2023
58. SOTO CL, Hsu AJ, Lee JH, Dzintars K, et al
    Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
    Clin Infect Dis. 2023 Aug 16:ciad476. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. HASEGAWA S, Livorsi DJ, Perencevich EN, Church JN, et al
    Diagnostic Accuracy of Hospital Antibiograms in Predicting the Risk of Antimicrobial Resistance in Enterobacteriaceae Isolates: A Nationwide Multicenter Evaluation at the Veterans Health Administration.
    Clin Infect Dis. 2023 Aug 10:ciad467. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
60. LIM LL, Worth LJ, Bull A
    Identifying Methicillin-resistant Staphylococcus aureus Colonization or Infection Using Administratively Coded Data.
    Clin Infect Dis. 2023;77:331-332.
    PubMed    
    
    
    
61. OLLIARO P, Nkeramahame J, Salami O, Moore CE, et al
    Advancing Access to Diagnostic Tools Essential for Universal Health Coverage and Antimicrobial Resistance Prevention: An Overview of Trials in Sub-Saharan Africa.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
62. KUKULA VA, Odopey S, Arthur E, Odonkor G, et al
    Understanding Health Worker and Community Antibiotic Prescription-Adherence Practices for Acute Febrile Illness: A Nested Qualitative Study in the Shai-Osudoku District of Ghana and the Development of a Training-and-Communication Intervention.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
63. COMPAORE A, Ekusai-Sebatta D, Kaawa-Mafigiri D, Kukula V, et al
    Viewpoint: Antimicrobial Resistance Diagnostics Use Accelerator: Qualitative Research on Adherence to Prescriptions.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
64. GUASTALEGNAME M, Trecarichi EM, Russo A
    Intravenous fosfomycin: the underdog player in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Clin Infect Dis. 2023 Jul 21:ciad435. doi: 10.1093.
    PubMed    
    
    
    
65. TAMMA PD, Aitken SL, Bonomo RA, Mathers AJ, et al
    Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.
    Clin Infect Dis. 2023 Jul 18:ciad428. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. CHOWDHURY F, Mah-E-Muneer S, Bollinger S, Sharma A, et al
    Prevalence of Colonization With Antibiotic-Resistant Organisms in Hospitalized and Community Individuals in Bangladesh, a Phenotypic Analysis: Findings From the Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
67. LESSA FC, Sievert DM
    Antibiotic Resistance: A Global Problem and the Need to Do More.
    Clin Infect Dis. 2023;77.
    PubMed    
    
    
    
68. CAUDELL MA, Ayodo C, Ita T, Smith RM, et al
    Risk Factors for Colonization With Multidrug-Resistant Bacteria in Urban and Rural Communities in Kenya: An Antimicrobial Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
69. RAMAY BM, Castillo C, Grajeda L, Santos LF, et al
    Colonization With Antibiotic-Resistant Bacteria in a Hospital and Associated Communities in Guatemala: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
70. BEZERRA CLPAM, Dos Santos EL, Oliveira MS, Dias MBS, et al
    Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
71. STYCZYNSKI A, Herzig C, Luvsansharav UO, McDonald LC, et al
    Using Colonization to Understand the Burden of Antimicrobial Resistance Across Low- and Middle-Income Countries.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
72. SALOMAO MC, Freire MP, Lazari CS, Cury AP, et al
    Transmission of Carbapenem-Resistant Enterobacterales in an Overcrowded Emergency Department: Controlling the Spread to the Hospital.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
73. ARAOS R, Smith RM, Styczynski A, Sanchez F, et al
    High Burden of Intestinal Colonization With Antimicrobial-Resistant Bacteria in Chile: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
74. OMULO S, Ita T, Mugoh R, Ayodo C, et al
    Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
75. KIFFER CRV, Rezende TFT, Costa-Nobre DT, Marinonio ASS, et al
    A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
76. LAUTENBACH E, Mosepele M, Smith RM, Styczynski A, et al
    Risk Factors for Community Colonization With Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    June 2023
77. EVANS ME, Simbartl LA, McCauley BP, Flarida LK, et al
    Active Surveillance and Contact Precautions for Preventing Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections during the COVID-19 Pandemic.
    Clin Infect Dis. 2023 Jun 30:ciad388. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. MURRAY GL, Plummer EL, Bodiyabadu K, Vodstrcil LA, et al
    gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.
    Clin Infect Dis. 2023;76:2187-2195.
    PubMed     Abstract available
    
    
    
79. KILEEL EM, Malvestutto CD, Lo J, Fitch KV, et al
    Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
    Clin Infect Dis. 2023;76:2010-2013.
    PubMed     Abstract available
    
    
    May 2023
80. HALEY CA, Schechter MC, Ashkin D, Peloquin CA, et al
    Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for treatment of rifampin-resistant or rifampin-intolerant TB disease.
    Clin Infect Dis. 2023 May 30:ciad312. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. PARCZEWSKI M, Jablonowska E, Wojcik-Cichy K, Zhyvytsia D, et al
    Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland.
    Clin Infect Dis. 2023;76:1708-1715.
    PubMed     Abstract available
    
    
    
82. MORTIMER TD, Grad YH
    A genomic perspective on the near-term impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance.
    Clin Infect Dis. 2023 May 4:ciad279. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. WATKINS RR, Du B, Isaacs R, Altarac D, et al
    Pathogen-Targeted Clinical Development to Address Unmet Medical Need: Design, Safety, and Efficacy of the ATTACK Trial.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available
    
    
    
84. CASTANHEIRA M, Mendes RE, Gales AC
    Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available
    
    
    
85. SHIELDS RK, Paterson DL, Tamma PD
    Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available
    
    
    
86. WATKINS RR, Bonomo RA
    Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections.
    Clin Infect Dis. 2023;76.
    PubMed     Abstract available
    
    
    March 2023
87. HUYGENS S, Dunbar A, Buil JB, Klaassen CHW, et al
    Clinical impact of PCR-based Aspergillus and azole resistance detection in invasive aspergillosis. A prospective multicenter study.
    Clin Infect Dis. 2023 Mar 11:ciad141. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. GONZALES-LUNA AJ, Dureja C, Eubank TA, Garey KW, et al
    Surveillance of Clostridioides difficile antimicrobial resistance in the United States.
    Clin Infect Dis. 2023 Mar 8:ciad135. doi: 10.1093.
    PubMed    
    
    
    
89. PARCZEWSKI M, Jablonowska E, Wojcik-Cichy K, Zhyvytsia D, et al
    Clinical perspective on HIV care of Ukrainian war refugees in Poland.
    Clin Infect Dis. 2023 Mar 8:ciad116. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. SOBEL JD
    New Antifungals for Vulvovaginal Candidiasis: What Is Their Role?
    Clin Infect Dis. 2023;76:783-785.
    PubMed     Abstract available
    
    
    February 2023
91. FALCONE M, Tiseo G, Carbonara S, Marino A, et al
    Mortality attributable to bloodstream infections caused by different carbapenem-resistant Gram negative bacilli: results from a nationwide study in Italy (ALARICO Network).
    Clin Infect Dis. 2023 Feb 21:ciad100. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. KISSLER SM, Wang B, Mehrotra A, Barnett M, et al
    Impact of Respiratory Infection and Chronic Comorbidities on Early Pediatric Antibiotic Dispensing in the United States.
    Clin Infect Dis. 2023;76:382-388.
    PubMed     Abstract available
    
    
    
93. KU JH, Henkle E, Carlson KF, Marino M, et al
    Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
    Clin Infect Dis. 2023;76:e1408-e1415.
    PubMed     Abstract available
    
    
    January 2023
94. 
    Correction to: Persistent Methicillin-resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management.
    Clin Infect Dis. 2023 Jan 21:ciad008. doi: 10.1093.
    PubMed    
    
    
    
95. BLANC P, Bonnet F, Leleux O, Perrier A, et al
    Severe bacterial non-AIDS infections in persons with HIV: the epidemiology and evolution of antibiotic resistance over an 18-year period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine cohort.
    Clin Infect Dis. 2023 Jan 4:ciac978. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2022
96. DE SALAZAR A, Vinuela L, Fuentes A, Teyssou E, et al
    Transmitted drug resistance to integrase based first-line HIV antiretroviral regimens in the Mediterranean Europe.
    Clin Infect Dis. 2022 Dec 26:ciac972. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. SIMNER PJ, Bard JD, Doern C, Johnson JK, et al
    REPORTing of Antimicrobial Resistance from Blood Cultures (REPORT-ABC), an ARLG Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures.
    Clin Infect Dis. 2022 Dec 19:ciac952. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
98. ALLAN-BLITZ LT, Adamson PC, Klausner JD
    Resistance-Guided Therapy for Neisseria gonorrhoeae.
    Clin Infect Dis. 2022;75:1655-1660.
    PubMed     Abstract available
    
    
    
99. TANG EC, Johnson KA, Alvarado L, Burghardt NO, et al
    Characterizing the Rise of Disseminated Gonococcal Infections in California, July 2020-July 2021.
    Clin Infect Dis. 2022 Oct 3. pii: 6746983. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2022
100. LUTERBACH CL, Chen L, Komarow L, Ostrowsky B, et al
     Transmission of Carbapenem-resistant Klebsiella pneumoniae in US hospitals.
     Clin Infect Dis. 2022 Sep 29. pii: 6731222. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. VODSTRCIL LA, Plummer EL, Doyle M, Murray GL, et al
     Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure.
     Clin Infect Dis. 2022;75:813-823.
     PubMed     Abstract available
     
     
     
102. DERESINSKI S
     OXA-48, AmpC, or Both-Activity of Some Newer ss-Lactams.
     Clin Infect Dis. 2022;75:i-ii.
     PubMed    
     
     
     August 2022
103. LAMOTH F, Lewis RE, Kontoyiannis DP
     Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective.
     Clin Infect Dis. 2022;75:534-544.
     PubMed     Abstract available
     
     
     
104. ROCK C, Hsu YJ, Curless MS, Carroll KC, et al
     Ultraviolet-C Light Evaluation as Adjunct Disinfection to Remove Multidrug-Resistant Organisms.
     Clin Infect Dis. 2022;75:35-40.
     PubMed     Abstract available
     
     
     
105. SIMNER PJ, Mostafa HH, Bergman Y, Ante M, et al
     Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression.
     Clin Infect Dis. 2022;75:47-54.
     PubMed     Abstract available
     
     
     
106. ROWLINSON E, Soge OO, Hughes JP, Berzkalns A, et al
     Prior exposure to azithromycin and azithromycin resistance among persons diagnosed with Neisseria gonorrhoeae infection at a Sexual Health Clinic 2012-2019.
     Clin Infect Dis. 2022 Aug 24. pii: 6674668. doi: 10.1093.
     PubMed     Abstract available
     
     
     
107. SMOKE SM, Brophy A, Reveron S, Iovleva A, et al
     Evolution and transmission of cefiderocol-resistant Acinetobacter baumannii during an outbreak in the burn intensive care unit.
     Clin Infect Dis. 2022 Aug 17. pii: 6668861. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2022
108. GETMAN D, Cohen S, Jiang A
     Distribution of Macrolide Resistant Mycoplasma genitalium in Urogenital Tract Specimens from Women Enrolled in a US Clinical Study Cohort.
     Clin Infect Dis. 2022 Jul 23. pii: 6649231. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. BAGGS J, Rose AN, McCarthy NL, Wolford H, et al
     Antibiotic Resistant Infections among COVID-19 Inpatients in U.S. Hospitals.
     Clin Infect Dis. 2022 Jul 2. pii: 6627591. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2022
110. HEYSELL SK, Mpagama SG, Ogarkov OB, Conaway M, et al
     Pharmacokinetic-pharmacodynamic determinants of clinical outcomes for rifampin-resistant tuberculosis: a multi-site prospective cohort study.
     Clin Infect Dis. 2022 Jun 22. pii: 6613372. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. WEERDENBURG E, Davies T, Morrow B, Zomer AL, et al
     Global Distribution of O-Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli (ExPEC) Collected From the Blood of Bacteremia Patients Across Multiple Surveillance Studies.
     Clin Infect Dis. 2022 Jun 10. pii: 6605050. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. ROGERS R, Krause PJ, Norris AM, Ting MH, et al
     Broad antimicrobial resistance in a case of relapsing babesiosis successfully treated with tafenoquine.
     Clin Infect Dis. 2022 Jun 10. pii: 6605069. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. LI Y, Rivers J, Mathis S, Li Z, et al
     Continued Increase of Erythromycin- and Clindamycin-Nonsusceptibility among Invasive Group A Streptococci Driven by Genomic Clusters, USA, 2018-2019.
     Clin Infect Dis. 2022 Jun 10. pii: 6605074. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2022
114. MILLER LG, Singh R, Eells SJ, Gillen D, et al
     Chlorhexidine and Mupirocin for Clearance of Methicillin Resistant Staphylococcus aureus Colonization After Hospital Discharge: A Secondary Analysis of the CLEAR Trial.
     Clin Infect Dis. 2022 May 31. pii: 6595699. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. PIDDOCK LJV, Paccaud JP, O'Brien S, Childs M, et al
     A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution.
     Clin Infect Dis. 2022;74:1866-1871.
     PubMed     Abstract available
     
     
     
116. SATLIN MJ, Chen L, Gomez-Simmonds A, Marino J, et al
     Impact of a Rapid Molecular Test for Klebsiella pneumoniae Carbapenemase and Ceftazidime-Avibactam Use on Outcomes after Bacteremia Caused by Carbapenem-Resistant Enterobacterales.
     Clin Infect Dis. 2022 May 6. pii: 6581726. doi: 10.1093.
     PubMed     Abstract available
     
     
     
117. YIN M
     Rapid diagnostics for antibiotic resistance: urgent need for strong clinical evidence.
     Clin Infect Dis. 2022 May 4. pii: 6580089. doi: 10.1093.
     PubMed    
     
     
     
118. TALBOT BM, Jacko NF, Petit RA, Pegues DA, et al
     Unsuspected clonal spread of Methicillin-resistant Staphylococcus aureus causing bloodstream infections in hospitalized adults detected using whole genome sequencing.
     Clin Infect Dis. 2022 May 1. pii: 6576473. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2022
119. TAMMA PD, Aitken SL, Bonomo RA, Mathers AJ, et al
     Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum beta-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (
     Clin Infect Dis. 2022 Apr 19. pii: 6570801. doi: 10.1093.
     PubMed     Abstract available
     
     
     
120. GRISKAITIS M, Furuya-Kanamori L, Allel K, Stabler R, et al
     beta-lactam resistant Streptococcus pneumoniae dynamics following treatment: a dose-response meta-analysis.
     Clin Infect Dis. 2022 Apr 19. pii: 6570668. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. BARBEE LA, St Cyr SB
     Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guideli
     Clin Infect Dis. 2022;74.
     PubMed     Abstract available
     
     
     
122. FARZANA R, Jones LS, Rahman MA, Sands K, et al
     Genomic insights into the mechanism of carbapenem resistance dissemination in Enterobacterales from a tertiary public heath setting in South Asia.
     Clin Infect Dis. 2022 Apr 12. pii: 6567427. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. ONG'UTI S, Czech M, Robilotti E, Holubar M, et al
     Cefiderocol: A New Cephalosporin Stratagem Against Multidrug-Resistant Gram-Negative Bacteria.
     Clin Infect Dis. 2022;74:1303-1312.
     PubMed     Abstract available
     
     
     
124. PATEL R, Polage CR, Dien Bard J, May L, et al
     Envisioning Future Urinary Tract Infection Diagnostics.
     Clin Infect Dis. 2022;74:1284-1292.
     PubMed     Abstract available
     
     
     March 2022
125. SHIVASABESAN G, Logan B, Brennan X, Lau C, et al
     Disseminated Aspergillus lentulus infection in a heart transplant recipient: a case report.
     Clin Infect Dis. 2022 Mar 11. pii: 6547270. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2022
126. HAYDEN FG, Asher J, Cowling BJ, Hurt AC, et al
     Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment.
     Clin Infect Dis. 2022;74:532-540.
     PubMed     Abstract available
     
     
     
127. GHARPURE R, Friedman CR, Fialkowski V, Collins JP, et al
     Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community-Vermont, 2018.
     Clin Infect Dis. 2022;74:455-460.
     PubMed     Abstract available
     
     
     
128. ZIEGLER MJ, Babcock HH, Welbel SF, Warren DK, et al
     Stopping Hospital Infections with Environmental Services (SHINE): A Cluster-Randomized Trial of Intensive Monitoring Methods for Terminal Room Cleaning on Rates of Multidrug-Resistant Organisms in the Intensive Care Unit.
     Clin Infect Dis. 2022 Feb 1. pii: 6518220. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2022
129. WESTON EJ, Heidenga BL, Farley MM, Tunali A, et al
     Surveillance for Disseminated Gonococcal Infections, Active Bacterial Core surveillance (ABCs) - United States, 2015-2019.
     Clin Infect Dis. 2022 Jan 28. pii: 6516834. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2021
130. BHATTARAI S, Sharma BK, Subedi N, Ranabhat S, et al
     Burden of Serious Bacterial Infections and Multidrug-Resistant Organisms in an Adult Population of Nepal: A Comparative Analysis of Minimally Invasive Tissue Sampling Informed Mortality Surveillance of Community and Hospital Deaths.
     Clin Infect Dis. 2021;73.
     PubMed     Abstract available
     
     
     
131. STRELING AP, Al Obaidi MM, Lainhart WD, Zangeneh T, et al
     Evolution of Cefiderocol Non-Susceptibility in Pseudomonas aeruginosa in a Patient Without Previous Exposure to the Antibiotic.
     Clin Infect Dis. 2021;73:e4472-e4474.
     PubMed     Abstract available
     
     
     
132. TAMMA PD, Beisken S, Bergman Y, Posch AE, et al
     Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance.
     Clin Infect Dis. 2021;73:e4599-e4606.
     PubMed     Abstract available
     
     
     
133. KOURTIS AP, Sheriff EA, Weiner-Lastinger LM, Elmore K, et al
     Antibiotic Multidrug Resistance of Escherichia coli Causing Device- and Procedure-related Infections in the United States Reported to the National Healthcare Safety Network, 2013-2017.
     Clin Infect Dis. 2021;73:e4552-e4559.
     PubMed     Abstract available
     
     
     
134. BHUTTA ZA
     International Travel and the Risk of Extensively Drug-resistant Typhoid: Issues and Potential Solutions.
     Clin Infect Dis. 2021;73:e4590-e4591.
     PubMed    
     
     
     
135. KNOX J, Uhlemann AC, Lowy FD
     Stopping Household Methicillin-resistant Staphylococcusaureus Transmission and Recurrent Infections: An Unmet Challenge.
     Clin Infect Dis. 2021;73:e4578-e4580.
     PubMed    
     
     
     
136. TAMMA PD, Aitken SL, Bonomo RA, Mathers AJ, et al
     Infectious Diseases Society of America Guidance on the Treatment of AmpC beta-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.
     Clin Infect Dis. 2021 Dec 5. pii: 6453394. doi: 10.1093/cid/ciab1013.
     PubMed     Abstract available
     
     
     
137. AVERY RK, Alain S, Alexander BD, Blumberg EA, et al
     Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results from a Phase 3 Randomized Clinical Trial.
     Clin Infect Dis. 2021 Dec 2. pii: 6448443. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. AFOLAYAN AO, Oaikhena AO, Aboderin AO, Olabisi OF, et al
     Clones and Clusters of Antimicrobial-Resistant Klebsiella From Southwestern Nigeria.
     Clin Infect Dis. 2021;73.
     PubMed     Abstract available
     
     
     
139. KEKRE M, Arevalo SA, Valencia MF, Lagrada ML, et al
     Integrating Scalable Genome Sequencing Into Microbiology Laboratories for Routine Antimicrobial Resistance Surveillance.
     Clin Infect Dis. 2021;73.
     PubMed     Abstract available
     
     
     
140. SAAVEDRA SY, Bernal JF, Montilla-Escudero E, Arevalo SA, et al
     Complexity of Genomic Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Isolates in Colombia Urges the Reinforcement of Whole Genome Sequencing-Based Surveillance Programs.
     Clin Infect Dis. 2021;73.
     PubMed     Abstract available
     
     
     
141. NAGARAJ G, Shamanna V, Govindan V, Rose S, et al
     High-Resolution Genomic Profiling of Carbapenem-Resistant Klebsiella pneumoniae Isolates: A Multicentric Retrospective Indian Study.
     Clin Infect Dis. 2021;73.
     PubMed     Abstract available
     
     
     
142. ABRUDAN M, Matimba A, Nikolic D, Hughes D, et al
     Train-the-Trainer as an Effective Approach to Building Global Networks of Experts in Genomic Surveillance of Antimicrobial Resistance (AMR).
     Clin Infect Dis. 2021;73.
     PubMed     Abstract available
     
     
     
143. AANENSEN DM, Carlos CC, Donado-Godoy P, Okeke IN, et al
     Implementing Whole-Genome Sequencing for Ongoing Surveillance of Antimicrobial Resistance: Exemplifying Insights Into Klebsiella pneumoniae.
     Clin Infect Dis. 2021;73.
     PubMed     Abstract available
     
     
     
144. ARGIMON S, David S, Underwood A, Abrudan M, et al
     Rapid Genomic Characterization and Global Surveillance of Klebsiella Using Pathogenwatch.
     Clin Infect Dis. 2021;73.
     PubMed     Abstract available
     
     
     November 2021
145. MORTIMER TD, Pathela P, Crawley A, Rakeman JL, et al
     The Distribution and Spread of Susceptible and Resistant Neisseria gonorrhoeae Across Demographic Groups in a Major Metropolitan Center.
     Clin Infect Dis. 2021;73:e3146-e3155.
     PubMed     Abstract available
     
     
     October 2021
146. ARGIMON S, Nagaraj G, Shamanna V, Darmavaram S, et al
     Circulation of third-generation cephalosporin resistant Salmonella Typhi in Mumbai, India.
     Clin Infect Dis. 2021 Oct 9. pii: 6385881. doi: 10.1093.
     PubMed     Abstract available
     
     
     
147. FOWLER VG, Jezek A, Spivak ES, Talkington K, et al
     Urgent, Comprehensive Federal Action Needed To Stem Mortality and Medicare Costs Associated With Antimicrobial Resistance.
     Clin Infect Dis. 2021 Oct 7. pii: 6374435. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. ARZIKA AM, Maliki R, Abdou A, Mankara AK, et al
     Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial.
     Clin Infect Dis. 2021;73:1292-1295.
     PubMed     Abstract available
     
     
     
149. HACKETT S, Teasdale CA, Pals S, Muttiti A, et al
     Drug Resistance Mutations Among South African Children Living With HIV on WHO-recommended ART Regimens.
     Clin Infect Dis. 2021;73:e2217-e2225.
     PubMed     Abstract available
     
     
     September 2021
150. KHATRI AM, Anderson AD, Camargo JF
     Addition Of Oral Fosfomycin To Antimicrobial Salvage Therapy For Persistent Vancomycin-Resistant Enterococcal Bacteremia.
     Clin Infect Dis. 2021 Sep 18. pii: 6372244. doi: 10.1093.
     PubMed    
     
     
     
151. AVEDISSIAN SN, Scheetz MH, Cortes-Penfield N
     Early Switch From Vancomycin to Daptomycin in Methicillin-Resistant Staphylococcus aureus Bacteremia: Still More Questions Than Answers.
     Clin Infect Dis. 2021;73:1128-1129.
     PubMed    
     
     
     
152. DIONNE B, Lee TC
     Probable Immortal Time Bias in Comparison of Daptomycin and Vancomycin for Methicillin-resistant Staphylococcus Aureus Bloodstream Infections.
     Clin Infect Dis. 2021;73:1127-1128.
     PubMed    
     
     
     
153. HOLDERMAN JL, Thomas JC, Schlanger K, Black JM, et al
     Sustained Transmission of Neisseria gonorrhoeae with High-Level Resistance to Azithromycin, in Indianapolis, Indiana, 2017-2018.
     Clin Infect Dis. 2021;73:808-815.
     PubMed     Abstract available
     
     
     August 2021
154. CURREN EJ, Lutgring JD, Kabbani S, Diekema DJ, et al
     Advancing Diagnostic Stewardship for Healthcare Associated Infections, Antibiotic Resistance, and Sepsis.
     Clin Infect Dis. 2021 Aug 4. pii: 6338696. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2021
155. KLAUSNER JD, Bristow CC, Soge OO, Shahkolahi A, et al
     Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.
     Clin Infect Dis. 2021;73:298-303.
     PubMed     Abstract available
     
     
     
156. ANDRIANAIVOARIMANANA V, Wagner DM, Birdsell DN, Nikolay B, et al
     Transmission of antimicrobial resistant Yersinia pestis during a pneumonic plague outbreak.
     Clin Infect Dis. 2021 Jul 9. pii: 6318455. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2021
157. MCCLUNG RP, Oster AM, Ocfemia MCB, Saduvala N, et al
     Transmitted Drug Resistance Among HIV-1 Diagnoses in the United States, 2014-2018.
     Clin Infect Dis. 2021 Jun 27. pii: 6310273. doi: 10.1093.
     PubMed     Abstract available
     
     
     
158. KAYE KS, Gupta V, Mulgirigama A, Joshi AV, et al
     Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011-2019: Rising ESBL Strains and Impact on Patient Management.
     Clin Infect Dis. 2021 Jun 18. pii: 6304915. doi: 10.1093.
     PubMed     Abstract available
     
     
     
159. STEWART AG, Satlin MJ, Schlebusch S, Isler B, et al
     Completing the Picture-Capturing the Resistome in Antibiotic Clinical Trials.
     Clin Infect Dis. 2021;72:e1122-e1129.
     PubMed     Abstract available
     
     
     
160. AL-HASAN MN
     Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target.
     Clin Infect Dis. 2021;72:2121-2123.
     PubMed    
     
     
     
161. KARLOWSKY JA, Lob SH, Raddatz J, DePestel DD, et al
     In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United S
     Clin Infect Dis. 2021;72:2112-2120.
     PubMed     Abstract available
     
     
     
162. KLEIN S, Boutin S, Kocer K, Fiedler MO, et al
     Rapid development of cefiderocol resistance in carbapenem-resistant Enterobacter cloacae during therapy is associated with heterogeneous mutations in the catecholate siderophore receptor cira.
     Clin Infect Dis. 2021 Jun 3. pii: 6291426. doi: 10.1093.
     PubMed     Abstract available
     
     
     
163. AZARIAN T
     The Importance of Pathogen Whole-Genome Sequencing in Evaluating Interventions to Reduce the Spread of Multidrug-Resistant Organisms in the Healthcare Setting.
     Clin Infect Dis. 2021;72:1888-1890.
     PubMed    
     
     
     
164. YAHAV D, Tau N, Shepshelovich D
     Assessment of Data Supporting the Efficacy of New Antibiotics for Treating Infections Caused by Multidrug-resistant Bacteria.
     Clin Infect Dis. 2021;72:1968-1974.
     PubMed     Abstract available
     
     
     May 2021
165. WRIGHT WF, Jorgensen SCJ, Spellberg B
     Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and Guidelines.
     Clin Infect Dis. 2021;72:e682-e684.
     PubMed    
     
     
     
166. HOUPT ER, Ferdous T, Ara R, Ibrahim M, et al
     Clinical Outcomes of Drug-resistant Shigellosis Treated With Azithromycin in Bangladesh.
     Clin Infect Dis. 2021;72:1793-1798.
     PubMed     Abstract available
     
     
     
167. ROYER G, Clermont O, Condamine B, Mercier-Darty M, et al
     O-antigen targeted vaccines against E. coli may be useful in reducing morbidity, mortality and antimicrobial resistance.
     Clin Infect Dis. 2021 May 17. pii: 6277090. doi: 10.1093.
     PubMed    
     
     
     
168. ROSE W, Fantl M, Geriak M, Nizet V, et al
     Current Paradigms of Combination therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination and For Which Patients?
     Clin Infect Dis. 2021 May 16. pii: 6276527. doi: 10.1093.
     PubMed     Abstract available
     
     
     
169. WILSON GM, Suda KJ, Fitzpatrick MA, Bartle B, et al
     Risk Factors Associated with Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Positive Cultures in a Cohort of U.S. Veterans.
     Clin Infect Dis. 2021 May 11. pii: 6273455. doi: 10.1093.
     PubMed     Abstract available
     
     
     
170. SATLIN MJ, Chen L, Douglass C, Hovan M, et al
     Colonization with Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
     Clin Infect Dis. 2021 May 6. pii: 6270940. doi: 10.1093.
     PubMed     Abstract available
     
     
     
171. KARCHMER AW
     Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia: Beauty Remains in the Eye of the Beholder.
     Clin Infect Dis. 2021;72:1526-1528.
     PubMed    
     
     
     April 2021
172. POTTS CC, Retchless AC, McNamara LA, Marasini D, et al
     Acquisition of ciprofloxacin resistance among an expanding clade of beta-lactamase positive, serogroup Y Neisseria meningitidis in the United States.
     Clin Infect Dis. 2021 Apr 26. pii: 6253703. doi: 10.1093.
     PubMed     Abstract available
     
     
     
173. GHANI R, Mullish BH, McDonald JAK, Ghazy A, et al
     Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms.
     Clin Infect Dis. 2021;72:1444-1447.
     PubMed     Abstract available
     
     
     
174. KHANNA S
     Microbiome-based Therapies for Multidrug-resistant Pathobionts: Getting a Step Closer!
     Clin Infect Dis. 2021;72:1448-1449.
     PubMed    
     
     
     
175. TAMMA PD, Aitken SL, Bonomo RA, Mathers AJ, et al
     Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum beta-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P
     Clin Infect Dis. 2021;72:1109-1116.
     PubMed     Abstract available
     
     
     March 2021
176. CAREY ME, Jain R, Yousuf M, Maes M, et al
     Spontaneous Emergence of Azithromycin Resistance in Independent Lineages of Salmonella Typhi in Northern India.
     Clin Infect Dis. 2021;72:e120-e127.
     PubMed     Abstract available
     
     
     February 2021
177. STRICH JR, Ricotta E, Warner S, Lai YL, et al
     Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals.
     Clin Infect Dis. 2021;72:611-621.
     PubMed     Abstract available
     
     
     
178. HARRIS PNA, Alexander M W
     Beyond the Core Genome: Tracking Plasmids in Outbreaks of Multidrug-resistant Bacteria.
     Clin Infect Dis. 2021;72:421-422.
     PubMed    
     
     
     
179. DE MAN TJB, Yaffee AQ, Zhu W, Batra D, et al
     Multispecies Outbreak of Verona Integron-Encoded Metallo-ss-Lactamase-Producing Multidrug Resistant Bacteria Driven by a Promiscuous Incompatibility Group A/C2 Plasmid.
     Clin Infect Dis. 2021;72:414-420.
     PubMed     Abstract available
     
     
     January 2021
180. TANNER WD, Leecaster MK, Zhang Y, Stratford KM, et al
     Environmental Contamination of Contact Precaution and Non-Contact Precaution Patient Rooms in Six Acute Care Facilities.
     Clin Infect Dis. 2021;72.
     PubMed     Abstract available
     
     
     
181. NELSON RE, Hatfield KM, Wolford H, Samore MH, et al
     National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States.
     Clin Infect Dis. 2021;72.
     PubMed     Abstract available
     
     
     
182. LIPWORTH S, Vihta KD, Chau KK, Kavanagh J, et al
     Ten years of population-level genomic Escherichia coli and Klebsiella pneumoniae serotype surveillance informs vaccine development for invasive infections.
     Clin Infect Dis. 2021 Jan 7. pii: 6067638. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2020
183. KENDALL EA, Kitonsa PJ, Nalutaaya A, Kamoga CE, et al
     The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities.
     Clin Infect Dis. 2020 Dec 6. pii: 6024999. doi: 10.1093/cid/ciaa1824.
     PubMed     Abstract available
     
     
     November 2020
184. WILSON BM, Jiang Y, Jump RLP, Colindres RV, et al
     Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance.
     Clin Infect Dis. 2020 Nov 27. pii: 6007573. doi: 10.1093/cid/ciaa1769.
     PubMed     Abstract available
     
     
     
185. IMLAY HN, Kaul DR
     Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients.
     Clin Infect Dis. 2020 Nov 17. pii: 5983750. doi: 10.1093/cid/ciaa1713.
     PubMed     Abstract available
     
     
     October 2020
186. PYNGOTTU A, Scherrer AU, Kouyos R, Huber M, et al
     Predictors of virological failure and time to viral suppression of first line integrase inhibitor based antiretroviral treatment.
     Clin Infect Dis. 2020 Oct 24. pii: 5937176. doi: 10.1093/cid/ciaa1614.
     PubMed     Abstract available
     
     
     August 2020
187. CROWELL TA, Danboise B, Parikh A, Esber A, et al
     Pre-Treatment and Acquired Antiretroviral Drug Resistance among Persons Living with HIV in Four African Countries.
     Clin Infect Dis. 2020 Aug 12. pii: 5891786. doi: 10.1093/cid/ciaa1161.
     PubMed     Abstract available
     
     
     June 2020
188. CHOI SH, Dagher M, Ruffin F, Park LP, et al
     Risk Factors for Recurrent Staphylococcus aureus Bacteremia.
     Clin Infect Dis. 2020 Jun 21. pii: 5860449. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2020
189. SULTAN AS, Vila T, Montelongo-Jauregui D, Jabra-Rizk MA, et al
     The Global Emergence of the Fungal Pathogen Candida auris.
     Clin Infect Dis. 2020 May 18. pii: 5838782. doi: 10.1093.
     PubMed    
     
     
     
190. DOOKIE N, Padayatchi N, Lessells RJ, Naicker CL, et al
     Individualised treatment of Multi-Drug Resistant Tuberculosis using Whole Genome Sequencing and Expanded Drug Susceptibility Testing.
     Clin Infect Dis. 2020 May 8. pii: 5834727. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2020
191. GORWOOD J, Bourgeois C, Pourcher V, Pourcher G, et al
     The integrase inhibitors dolutegravir and raltegravir exert pro-adipogenic and profibrotic effects and induce insulin resistance in human/simian adipose tissue and human adipocytes.
     Clin Infect Dis. 2020 Mar 13. pii: 5804258. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2020
192. MCGEE L, Chochua S, Li Z, Mathis S, et al
     Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015-2017.
     Clin Infect Dis. 2020 Feb 15. pii: 5736375. doi: 10.1093.
     PubMed     Abstract available
     
     
     
193. POPPING S, Verwijs R, Cuypers L, Claassen M, et al
     Transmission of NS5A resistance associated substitutions among men-who-have-sex-with-men recently infected with hepatitis C virus genotype 1a.
     Clin Infect Dis. 2020 Feb 14. pii: 5735665. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2019
194. WALLIS CL, Hughes MD, Ritz J, Viana R, et al
     Diverse HIV-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line ART in Resource Limited Settings.
     Clin Infect Dis. 2019 Nov 14. pii: 5625392. doi: 10.1093/cid/ciz1116.
     PubMed     Abstract available
     
     
     September 2019
195. SHAH M, Paradis S, Betz J, Beylis N, et al
     Multicenter Study of the Accuracy of the BD MAX MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid.
     Clin Infect Dis. 2019 Sep 27. pii: 5574845. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.